All News

katz-bw-square.jpg

Mourning the Loss of NIAMS Director Stephen Katz, MD, PhD

d Jack Cush, MD

The following tribute to the late Dr. Steven Katz appeared on the NIH website. 

Read Article
WIR.large_.jpg (keep)

RheumNow Podcast – Rheumatologist Salaries (12.21.18)

d Jack Cush, MD

Dr. Jack Cush reviews the news from RheumNow for the week ending 12/21/18.

Read Article
hip.fx2_.jpg

Zolendronate Protects Against Fracture in Osteopenia

d Jack Cush, MD

The NEJM reports that the use of zoledronate significantly reduces the risk of nonvertebral or vertebral fragility fractures in women with osteopenia.

Read Article
DVT.PE_.Blood_.jpg

Reassuring VTE Data for Tofacitinib

d RheumNow

No significant differences in risk for venous thromboembolism (VTE) were seen in patients with rheumatoid arthritis (RA) treated with tofacitinib (Xeljanz) and those receiving tumor necrosis factor (TNF) inhibitors, analysis of administrative data showed.

Read Article
Nailfold-capilaroscopy.jpg

Nailfold Videocapillaroscopy in Dermatomyositis

d Jack Cush, MD

A study of nailfold videocapillaroscopy (NVC) in patients with idiopathic inflammatory myopathies (IIMs) finds abnormalities in more than half of patients suggesting this could be a useful clinical tool in diagnosing and managing patients with IIM. 

Read Article
Rheum.Salary.jpg

Rheumatologist and Physician Salaries for 2018

d RheumNow

Medpage Today has published the results of their 2018 Rheumatology Specialty Salaray Survey.

Read Article
myositis.jpg

TIF1-Ab in Dermatomyositis Linked to Higher Cancer Risk

d RheumNow

Several epidemiological studies have reported that a diagnosis of DM or PM may be associated with increased cancer risk. The association appears stronger for DM than PM.

Read Article
pso.PsA_.NPF_.jpg

H2H: Ixekizumab vs. Adalimumab in Psoriatic Arthritis

d Jack Cush, MD

Lilly has issued an advanced press release on its SPIRIT-H2H trial, wherein ixekizumab (Taltz) was shown to be more effective than than adalimumab (Humira) in a 24 week psoriatic arthritis study.

Read Article
medicare.jpg (keep)

Rising Physician Exclusion from Medicare and Medicaid

d Jack Cush, MD

JAMA Network Open has published that an increasing number of physicians are being excluded from Medicare and other forms of public insurance. 

Read Article
cryotherapy.jpg

Cryotherapy Never FDA Approved

d RheumNow

Another injury related to whole body cryotherapy (WBC) has been reported by practitioners in Philadelphia, serving as yet another warning of WBC's potential to cause serious adverse effects.

Read Article
RheumNow LIve - the next best 2day CME weekend meeting for Rheumtologists!. Now with discounted registration for the holidays. Check out this high interactive, Q&A, Panel driven, audience focused meeting. March 22-24, 2019. --> https://t.co/2dcFVgu8z6

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow week in review is out. https://t.co/4WCDIftZW3

Links:

Dr. John Cush RheumNow ( View Tweet)

Study from the UK BSRBR registry shows 34 cancers & 41 deaths in 709 pts. Risk of CA w/ TNFi was not increased (SIR 0.94; 95% CI 0.65,1.34) (but for 2 fold incr risk of nonmelanoma skin CA) & all-cause mortality rate was increased (SMR 1.56) from CV events https://t.co/6HSnw5SOF8

Links:

Dr. John Cush RheumNow ( View Tweet)

Case reports of non-infectious pneumonia with Ustekinumab reported from FDA Adverse Event Reporting System (medwatch) - 12 cases, 7 interstitial pneumonia, 3 eosinophilic pneumonia, 1 each organizing pneumonia & hypersensitivity pneumonitis https://t.co/r9zGR0nTmc

Links:

Dr. John Cush RheumNow ( View Tweet)

Clinical pain severity & disability in OA is higher amongst African Americans vs Whites. Metanalysis of 61 articles shows higher pain severity in AA using the WOMAC (0.57; 95%CI: 0.54, 0.61) & non-WOMAC studies (0.35; 95%CI: 0.23, 0.47). Journal of Pain. https://t.co/qLm2Pbw7pz

Links:

Dr. John Cush RheumNow ( View Tweet)

Retrospective study of 282 Bx proven Temporal arteritis pts (Northern Italy) finds increased mortality associated with large vessel Dz (HR 5.14) at diagnosis and reduced mortality with PMR (HR 0.57) at Dx and adventitial inflammation (HR 0.31) on Bx. https://t.co/iF90cqYtqn

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast is up - Vasculitis and strange bedfellows. Watch here https://t.co/SEw0RojCBB or listen on iTunes or here https://t.co/8StKrqV11F

Links:

Dr. John Cush RheumNow ( View Tweet)

Check out Vinay Prasads @VPplenarysesh Plenary Session Podcast that discusses studies on Fish oils and MTX in cardiology - the CIRT NEJM study appears at 35:23 - interesting to hear non-Rheum views on this approach https://t.co/MQCWLYgEnD

Links:

Dr. John Cush RheumNow ( View Tweet)

Metanalysis of 24 PPI studies, 319,568 hip fracture pts, suggests PPIs associated with a greater risk of hip fracture (RR 1.20, 95% CI 1.14–1.28, p < 0.0001) and may be greater with higher dose (RR 1.30, 95% CI 1.20–1.40, p < 0.0001). https://t.co/nbiEIPRaXg

Links:

Dr. John Cush RheumNow ( View Tweet)

Len Calabrese says its about time Rheumatologists tap into new ways of learning - social media, the ACR Meeting App, Websites covering the meetings and journals. Time to get on the bus! https://t.co/pRdJqGv3OM

Links:

Dr. John Cush RheumNow ( View Tweet)

×